Evidence for a Novel Mechanism of Influenza Virus-Induced Type I Interferon Expression by a Defective RNA-Encoded Protein

1. Wise HM, Foeglein A, Sun J, Dalton RM, Patel S, Howard W, Anderson EC, Barclay WS, Digard P. A complicated message: Identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J Virol. 2009 Aug;83(16):8021–31. doi: 10.1128/JVI.00826-09 19494001

2. Wise HM, Hutchinson EC, Jagger BW, Stuart AD, Kang ZH, Robb N, Schwartzman LM, Kash JC, Fodor E, Firth AE, Gog JR, Taubenberger JK, Digard P. Identification of a novel splice variant form of the influenza a virus m2 ion channel with an antigenically distinct ectodomain. PLoS Pathog. 2012 Nov;8(11):e1002998. doi: 10.1371/journal.ppat.1002998 23133386

3. Jagger BW, Wise HM, Kash JC, Walters KA, Wills NM, Xiao YL, Dunfee RL, Schwartzman LM, Ozinsky A, Bell GL, Dalton RM, Lo A, Efstathiou S, Atkins JF, Firth AE, Taubenberger JK, Digard P. An overlapping protein-coding region in influenza A virus segment 3 modulates the host response. Science. 2012 Jul 13;337(6091):199–204. doi: 10.1126/science.1222213 22745253

4. Muramoto Y, Noda T, Kawakami E, Akkina R, Kawaoka Y. Identification of novel influenza A virus proteins translated from PA mRNA. J Virol. 2013 Mar;87(5):2455–62. doi: 10.1128/JVI.02656-12 23236060

5. Bouvier NM, Palese P. The biology of influenza viruses. Vaccine. 2008 Sep 12;26 Suppl 4:D49–53. 19230160

6. Hutchinson EC, von Kirchbach JC, Gog JR, Digard P. Genome packaging in influenza A virus. J Gen Virol. 2010 Feb;91(Pt 2):313–28.

7. Davis AR, Hiti AL, Nayak DP. Influenza defective interfering viral RNA is formed by internal deletion of genomic RNA. Proc Natl Acad Sci U S A. 1980 Jan;77(1):215–9. 6928614

8. Nayak DP, Sivasubramanian N, Davis AR, Cortini R, Sung J. Complete sequence analyses show that two defective interfering influenza viral RNAs contain a single internal deletion of a polymerase gene. Proc Natl Acad Sci U S A. 1982 Apr;79(7):2216–20. 6954536

9. Huang AS, Baltimore D. Defective viral particles and viral disease processes. Nature. 1970 Apr 25;226(5243):325–7. 5439728

10. Jennings PA, Finch JT, Winter G, Robertson JS. Does the higher order structure of the influenza virus ribonucleoprotein guide sequence rearrangements in influenza viral RNA? Cell. 1983 Sep;34(2):619–27. 6616623

11. Marriott AC, Dimmock NJ. Defective interfering viruses and their potential as antiviral agents. Rev Med Virol. 2010 Jan;20(1):51–62. doi: 10.1002/rmv.641 20041441

12. Odagiri T, Tashiro M. Segment-specific noncoding sequences of the influenza virus genome RNA are involved in the specific competition between defective interfering RNA and its progenitor RNA segment at the virion assembly step. J Virol. 1997 Mar;71(3):2138–45. 9032347

13. Odagiri T, Tominaga K, Tobita K, Ohta S. An amino acid change in the non-structural NS2 protein of an influenza A virus mutant is responsible for the generation of defective interfering (DI) particles by amplifying DI RNAs and suppressing complementary RNA synthesis. J Gen Virol. 1994 Jan;75 (Pt 1)(Pt 1):43–53.

14. Janda JM, Davis AR, Nayak DP, De BK. Diversity and generation of defective interfering influenza virus particles. Virology. 1979 May;95(1):48–58. 442544

15. Von Magnus P. Propagation of the PR8 strain of influenza A virus in chick embryos. III. properties of the incomplete virus produced in serial passages of undiluted virus. Acta Pathol Microbiol Scand. 1951;29(2):157–81. 14902470

16. Saira K, Lin X, DePasse JV, Halpin R, Twaddle A, Stockwell T, Angus B, Cozzi-Lepri A, Delfino M, Dugan V, Dwyer DE, Freiberg M, Horban A, Losso M, Lynfield R, Wentworth DN, Holmes EC, Davey R, Wentworth DE, Ghedin E, INSIGHT FLU002 Study Group, INSIGHT FLU003 Study Group. Sequence analysis of in vivo defective interfering-like RNA of influenza A H1N1 pandemic virus. J Virol. 2013 Jul;87(14):8064–74. doi: 10.1128/JVI.00240-13 23678180

17. Baum A, Sachidanandam R, Garcia-Sastre A. Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing. Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16303–8. doi: 10.1073/pnas.1005077107 20805493

18. Randall RE, Goodbourn S. Interferons and viruses: An interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol. 2008 Jan;89(Pt 1):1–47. 18089727

19. Tapia K, Kim WK, Sun Y, Mercado-Lopez X, Dunay E, Wise M, Adu M, Lopez CB. Defective viral genomes arising in vivo provide critical danger signals for the triggering of lung antiviral immunity. PLoS Pathog. 2013 Oct;9(10):e1003703. doi: 10.1371/journal.ppat.1003703 24204261

20. Penn CR, Mahy BW. Novel polypeptides encoded by influenza virus subgenomic (DI type) virion RNAs. Virus Res. 1985 Nov;3(4):311–21. 4072398

21. Akkina RK, Chambers TM, Nayak DP. Expression of defective-interfering influenza virus-specific transcripts and polypeptides in infected cells. J Virol. 1984 Aug;51(2):395–403. 6205168

22. Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, Bacik I, Basta S, O'Neill R, Schickli J, Palese P, Henklein P, Bennink JR, Yewdell JW. A novel influenza A virus mitochondrial protein that induces cell death. Nat Med. 2001 Dec;7(12):1306–12. 11726970

23. Tauber S, Ligertwood Y, Quigg-Nicol M, Dutia BM, Elliott RM. Behaviour of influenza A viruses differentially expressing segment 2 gene products in vitro and in vivo. J Gen Virol. 2012 Apr;93(Pt 4):840–9. doi: 10.1099/vir.0.039966-0 22190016

24. Schmolke M, Manicassamy B, Pena L, Sutton T, Hai R, Varga ZT, Hale BG, Steel J, Perez DR, Garcia-Sastre A. Differential contribution of PB1-F2 to the virulence of highly pathogenic H5N1 influenza A virus in mammalian and avian species. PLoS Pathog. 2011 Aug;7(8):e1002186. doi: 10.1371/journal.ppat.1002186 21852950

25. Mazur I, Anhlan D, Mitzner D, Wixler L, Schubert U, Ludwig S. The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein. Cell Microbiol. 2008 May;10(5):1140–52. doi: 10.1111/j.1462-5822.2008.01116.x 18182088

26. Dudek SE, Wixler L, Nordhoff C, Nordmann A, Anhlan D, Wixler V, Ludwig S. The influenza virus PB1-F2 protein has interferon antagonistic activity. Biol Chem. 2011 Dec;392(12):1135–44. doi: 10.1515/BC.2011.174 22050228

27. Varga ZT, Ramos I, Hai R, Schmolke M, Garcia-Sastre A, Fernandez-Sesma A, Palese P. The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS Pathog. 2011 Jun;7(6):e1002067. doi: 10.1371/journal.ppat.1002067 21695240

28. Bao Y, Bolotov P, Dernovoy D, Kiryutin B, Zaslavsky L, Tatusova T, Ostell J, Lipman D. The influenza virus resource at the national center for biotechnology information. J Virol. 2008 Jan;82(2):596–601. 17942553

29. Nayak DP, Tobita K, Janda JM, Davis AR, De BK. Homologous interference mediated by defective interfering influenza virus derived from a temperature-sensitive mutant of influenza virus. J Virol. 1978 Oct;28(1):375–86. 702654

30. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A. 2000 May 23;97(11):6108–13. 10801978

31. Dimmock NJ, Rainsford EW, Scott PD, Marriott AC. Influenza virus protecting RNA: An effective prophylactic and therapeutic antiviral. J Virol. 2008 Sep;82(17):8570–8. doi: 10.1128/JVI.00743-08 18579602

32. Easton AJ, Scott PD, Edworthy NL, Meng B, Marriott AC, Dimmock NJ. A novel broad-spectrum treatment for respiratory virus infections: Influenza-based defective interfering virus provides protection against pneumovirus infection in vivo. Vaccine. 2011 Mar 24;29(15):2777–84. doi: 10.1016/j.vaccine.2011.01.102 21320545

33. Scott PD, Meng B, Marriott AC, Easton AJ, Dimmock NJ. Defective interfering influenza A virus protects in vivo against disease caused by a heterologous influenza B virus. J Gen Virol. 2011 Sep;92(Pt 9):2122–32. doi: 10.1099/vir.0.034132-0 21632569

34. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, Reis e Sousa C. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science. 2006 Nov 10;314(5801):997–1001. 17038589

35. Koerner I, Kochs G, Kalinke U, Weiss S, Staeheli P. Protective role of beta interferon in host defense against influenza A virus. J Virol. 2007 Feb;81(4):2025–30. 17151098

36. Brown EG, Liu H, Kit LC, Baird S, Nesrallah M. Pattern of mutation in the genome of influenza A virus on adaptation to increased virulence in the mouse lung: Identification of functional themes. Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6883–8. 11371620

37. Gabriel G, Dauber B, Wolff T, Planz O, Klenk HD, Stech J. The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18590–5. 16339318

38. Hatta M, Gao P, Halfmann P, Kawaoka Y. Molecular basis for high virulence of hong kong H5N1 influenza A viruses. Science. 2001 Sep 7;293(5536):1840–2. 11546875

39. Mehle A, Doudna JA. An inhibitory activity in human cells restricts the function of an avian-like influenza virus polymerase. Cell Host Microbe. 2008 Aug 14;4(2):111–22. doi: 10.1016/j.chom.2008.06.007 18692771

40. Graef KM, Vreede FT, Lau YF, McCall AW, Carr SM, Subbarao K, Fodor E. The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon. J Virol. 2010 Sep;84(17):8433–45. doi: 10.1128/JVI.00879-10 20538852

41. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell. 2005 Sep 16;19(6):727–40. 16153868

42. Seth RB, Sun L, Ea CK, Chen ZJ. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell. 2005 Sep 9;122(5):669–82. 16125763

43. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, Tschopp J. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature. 2005 Oct 20;437(7062):1167–72. 16177806

44. Patel D, Schultz LW, Umland TC. Influenza A polymerase subunit PB2 possesses overlapping binding sites for polymerase subunit PB1 and human MAVS proteins. Virus Res. 2012 Dec 12

45. Carr SM, Carnero E, Garcia-Sastre A, Brownlee GG, Fodor E. Characterization of a mitochondrial-targeting signal in the PB2 protein of influenza viruses. Virology. 2006 Jan 20;344(2):492–508. 16242167

46. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S. IPS-1, an adaptor triggering RIG-I -⁠ and Mda5-mediated type I interferon induction. Nat Immunol. 2005 Oct;6(10):981–8. 16127453

47. Kochs G, Garcia-Sastre A, Martinez-Sobrido L. Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol. 2007 Jul;81(13):7011–21. 17442719

48. Iwai A, Shiozaki T, Kawai T, Akira S, Kawaoka Y, Takada A, Kida H, Miyazaki T. Influenza A virus polymerase inhibits type I interferon induction by binding to interferon beta promoter stimulator 1. J Biol Chem. 2010 Oct 15;285(42):32064–74. doi: 10.1074/jbc.M110.112458 20699220

49. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, Qui PT, Cam BV, Ha do Q, Guan Y, Peiris JS, Chinh NT, Hien TT, Farrar J. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 2006 Oct;12(10):1203–7. 16964257

50. Cilloniz C, Shinya K, Peng X, Korth MJ, Proll SC, Aicher LD, Carter VS, Chang JH, Kobasa D, Feldmann F, Strong JE, Feldmann H, Kawaoka Y, Katze MG. Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog. 2009 Oct;5(10):e1000604. doi: 10.1371/journal.ppat.1000604 19798428

51. Carter MJ, Mahy BW. Incomplete avian influenza virus contains a defective non-interfering component. Arch Virol. 1982;71(1):13–25. 7065901

52. Brooke CB. Biological activities of 'noninfectious' influenza A virus particles. Future Virol. 2014 Jan;9(1):41–51. 25067941

53. Sugiyama K, Obayashi E, Kawaguchi A, Suzuki Y, Tame JR, Nagata K, Park SY. Structural insight into the essential PB1-PB2 subunit contact of the influenza virus RNA polymerase. EMBO J. 2009 Jun 17;28(12):1803–11. doi: 10.1038/emboj.2009.138 19461581

54. Poole E, Elton D, Medcalf L, Digard P. Functional domains of the influenza A virus PB2 protein: Identification of NP -⁠ and PB1-binding sites. Virology. 2004 Mar 30;321(1):120–33. 15033571

55. Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, Shortridge KF, Gordon S, Guan Y, Peiris JS. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: A mechanism for the unusual severity of human disease? Lancet. 2002 Dec 7;360(9348):1831–7. 12480361

56. Teijaro JR, Walsh KB, Cahalan S, Fremgen DM, Roberts E, Scott F, Martinborough E, Peach R, Oldstone MB, Rosen H. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell. 2011 Sep 16;146(6):980–91. doi: 10.1016/j.cell.2011.08.015 21925319

57. Börgeling Y, Schmolke M, Viemann D, Nordhoff C, Roth J, Ludwig S. Inhibition of p38 mitogen-activated protein kinase impairs influenza virus-induced primary and secondary host gene responses and protects mice from lethal H5N1 infection. J Biol Chem. 2014 Jan 3;289(1):13–27. doi: 10.1074/jbc.M113.469239 24189062

58. Abt M, de Jonge J, Laue M, Wolff T. Improvement of H5N1 influenza vaccine viruses: Influence of internal gene segments of avian and human origin on production and hemagglutinin content. Vaccine. 2011 Jul 18;29(32):5153–62. doi: 10.1016/j.vaccine.2011.05.036 21624413

59. Zielecki F, Semmler I, Kalthoff D, Voss D, Mauel S, Gruber AD, Beer M, Wolff T. Virulence determinants of avian H5N1 influenza A virus in mammalian and avian hosts: Role of the C-terminal ESEV motif in the viral NS1 protein. J Virol. 2010 Oct;84(20):10708–18. doi: 10.1128/JVI.00610-10 20686040

60. Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR. Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol. 2001 Dec;146(12):2275–89. 11811679

61. Seyer R, Hrincius ER, Ritzel D, Abt M, Mellmann A, Marjuki H, Kuhn J, Wolff T, Ludwig S, Ehrhardt C. Synergistic adaptive mutations in the hemagglutinin and polymerase acidic protein lead to increased virulence of pandemic 2009 H1N1 influenza A virus in mice. J Infect Dis. 2012 Jan 15;205(2):262–71. doi: 10.1093/infdis/jir716 22102733

62. Borchert N, Dieterich C, Krug K, Schutz W, Jung S, Nordheim A, Sommer RJ, Macek B. Proteogenomics of pristionchus pacificus reveals distinct proteome structure of nematode models. Genome Res. 2010 Jun;20(6):837–46. doi: 10.1101/gr.103119.109 20237107

63. Rappsilber J, Mann M, Ishihama Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat Protoc. 2007;2(8):1896–906. 17703201

64. Carpy A, Krug K, Graf S, Koch A, Popic S, Hauf S, Macek B. Absolute proteome and phosphoproteome dynamics during the cell cycle of schizosaccharomyces pombe (fission yeast). Mol Cell Proteomics. 2014 Aug;13(8):1925–36. doi: 10.1074/mcp.M113.035824 24763107

65. Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008 Dec;26(12):1367–72. doi: 10.1038/nbt.1511 19029910

66. Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, Mann M. Andromeda: A peptide search engine integrated into the MaxQuant environment. J Proteome Res. 2011 Apr 1;10(4):1794–805. doi: 10.1021/pr101065j 21254760

67. Elias JE, Gygi SP. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat Methods. 2007 Mar;4(3):207–14. 17327847

68. Luig C, Kother K, Dudek SE, Gaestel M, Hiscott J, Wixler V, Ludwig S. MAP kinase-activated protein kinases 2 and 3 are required for influenza A virus propagation and act via inhibition of PKR. FASEB J. 2010 Oct;24(10):4068–77. doi: 10.1096/fj.10-158766 20484669

69. Ehrhardt C, Schmolke M, Matzke A, Knoblauch A, Will C, Wixler V, Ludwig S. Polyethylenimine, a cost-effective transfection reagent. Signal Transduction. 2006;6(3):179–84.

70. Ehrhardt C, Kardinal C, Wurzer WJ, Wolff T, von Eichel-Streiber C, Pleschka S, Planz O, Ludwig S. Rac1 and PAK1 are upstream of IKK-epsilon and TBK-1 in the viral activation of interferon regulatory factor-3. FEBS Lett. 2004 Jun 4;567(2–3):230–8. 15178349

71. Kawakami E, Watanabe T, Fujii K, Goto H, Watanabe S, Noda T, Kawaoka Y. Strand-specific real-time RT-PCR for distinguishing influenza vRNA, cRNA, and mRNA. J Virol Methods. 2011 Apr;173(1):1–6. doi: 10.1016/j.jviromet.2010.12.014 21185869

72. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 2001 Dec;25(4):402–8. 11846609

73. Mo D, Raabe CA, Reinhardt R, Brosius J, Rozhdestvensky TS. Alternative processing as evolutionary mechanism for the origin of novel nonprotein coding RNAs. Genome Biol Evol. 2013;5(11):2061–71. doi: 10.1093/gbe/evt155 24132753